Exchange: NYSE·Updated 06:49 PM EST

OACB Oaktree Acquisition Corp II - Ordinary Shares - Class A

$4.89
$0.31
(6.81%)
Today
Closed $4.86
$0.03
(0.62%)
After Hours
Mkt Cap$1.78B
Vol1.02M

About OACB

Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focusing on the development of its product candidates. It operates through the following geographical segments: Europe, North America, Asia, and Other. The company was founded by Róbert Vilhelm Wessman in 2013 and is headquartered in Luxembourg.
50

Neutral Sentiment

How do you feel about OACB?

Advertisement|Remove ads.